REX vs BIOX

For growth investors, REX American Resources Corporation (REX) is the stronger pick with -22.

9% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). REX American Resources Corporation (REX) offers the better valuation at 29. 1x trailing P/E (62. 0x forward), making it the more compelling value choice. Analysts rate REX American Resources Corporation (REX) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +252.

3%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: REX returned +448. 8% versus BIOX's -95. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.

36β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 432% more volatile than REX relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), REX American Resources Corporation (REX) is pulling ahead at -22.

9% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: REX American Resources Corporation grew EPS -4. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

REX American Resources Corporation (REX) is the more profitable company, earning 9.

1% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -1. 1% for BIOX. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

36), +448. 8% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +448. 8%, BIOX: -95. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.